首页> 外国专利> Donor KIR3DL1 and HLA-B subtypes and leukemia control in HLA-compatible allogenic hematopoietic stem cell transplantation

Donor KIR3DL1 and HLA-B subtypes and leukemia control in HLA-compatible allogenic hematopoietic stem cell transplantation

机译：HLA相容性同种异体造血干细胞移植中的供体 KIR3DL1 和 HLA-B 亚型和白血病控制

展开▼

页面导航

摘要

著录项

相似文献

摘要

This disclosure generally relates to donor selection for hematopoietic stem cell transplantation. In particular, this disclosure relates to typing KIR3DL1 and HLA-B alleles as basis for donor selection. 展开▼

机译：本公开总体上涉及用于造血干细胞移植的供体选择。特别地，本公开涉及将KIR3DL1和HLA-B等位基因分型作为供体选择的基础。展开▼

著录项

公开/公告号US10407727B2

专利类型

公开/公告日2019-09-10

原文格式PDF

申请/专利权人 MEMORIAL SLOAN-KETTERING CANCER CENTER;
展开▼

申请/专利号US201414764854

发明设计人 KATHARINE HSU;
展开▼

申请日2014-01-30

分类号C12Q1/68;C12P19/34;C12Q1/6886;C12Q1/6881;A61K35/28;C07H21/02;C07H21/04;

国家 US

入库时间 2022-08-21 12:12:30

相似文献

专利

外文文献

中文文献

1. HLA-B*59:01和HLA-B*55:02在评价醋甲唑胺所致药疹发生中的应用 [P] . 中国专利： CN111763727B . 2022.02.08

2. HLA-B*59:01和HLA-B*55:02在评价醋甲唑胺所致药疹发生中的应用 [P] . 中国专利： CN111763727A . 2020-10-13

3. DONOR KIR3DL1 AND HLA-B SUBTYPES AND LEUKEMIA CONTROL IN HLA-COMPATIBLE ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION [P] . 美国专利： US2015361506A1 . 2015-12-17

机译：兼容HLA的同种异基因造血干细胞移植中的供体KIR3DL1和HLA-B亚型和白血病控制

4. DONOR KIR3DL1 AND HLA-B SUBTYPES AND LEUKEMIA CONTROL IN HLA-COMPATIBLE ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION [P] . 世界知识产权组织专利： WO2014120949A1 . 2014-08-07

机译：兼容HLA的同种异基因造血干细胞移植中的供体KIR3DL1和HLA-B亚型和白血病控制

5. KIR3DL1/HLA-B SUBTYPES FOR HEMATOPOIETIC CELL TRANSPLANTATION DONOR SELECTION [P] . 欧洲知识产权局专利： EP3595448A1 . 2020-01-22

机译：用于造血细胞移植供体选择的KIR3DL1 / HLA-B亚型

1. Donor-Derived CD19-Targeted T Cell Infusion Eliminates B Cell Acute Lymphoblastic Leukemia Minimal Residual Disease with No Response to Donor Lymphocytes after Allogeneic Hematopoietic Stem Cell Transplantation [J] . Yifei Cheng, Kaiyan Liu, Shasha Wang, 工程（英文） . 2019,第001期

2. Donor-Derived CD19-Targeted T Cell Infusion Eliminates B Cell Acute Lymphoblastic Leukemia Minimal Residual Disease with No Response to Donor Lymphocytes after Allogeneic Hematopoietic Stem Cell Transplantation [J] . Yifei Cheng, Yuhong Chen, Chenhua Yan, 工程（英文） . 2019,第001期

3. Rapid identification of the origin of hematopoietic cells after allogeneic hematopoietic stem cell transplantation for leukemia with DNA-fingerprinting [J] . 钱新华, 邢献志, 朱为国, 中国人民解放军军医大学学报：英文版 . 1997,第001期

4. KIR3DL1/HLA-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell Transplantation [J] . Boudreau Jeanette E., Giglio Fabio, Gooley Ted A., Journal of Clinical Oncology . 2017,第20期

5. Comparison of survival outcome between donor types or stem cell sources for childhood acute myeloid leukemia after allogenic hematopoietic stem cell transplantation: A multicenter retrospective study of Study Alliance of Yeungnam Pediatric Hematology‐oncology [J] . Shim Ye Jee, Lee Jae Min, Kim Heung Sik, Pediatric transplantation. . 2018,第6期

6. The reactivity of Bw4+ HLA-B and HLA-A alleles with KIR3DL1: implications for patient and donor suitability for haploidentical stem cell transplantations. [J] . Foley BA, De-Santis D, Van-Beelen E, Blood: The Journal of the American Society of Hematology . 2008,第2期

7. DONOR-SPECIFIC (DSA) ANTI-DP ANTIBODIES ASSOCIATE WITH GRAFT FAILURE IN MATCHED UNRELATED DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION [C] . Stefan O. Ciurea, Fleur Aung, Pedro Cano, Clinical Histocompatibility Workshop. . 2010

8. Genetic Associations in Acute Leukemia Patients After Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation [D] . Rizvi, Abbas A. 2019

9. KIR3DL1/HLA-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell Transplantation [O] . Jeanette E. Boudreau, Fabio Giglio, Ted A. Gooley, -1

10. KIR3DL1/S1 and HLA-B Alleles Combine to Influence Unrelated Hematopoietic Stem Cell Transplantation (HSCT) Outcomes [O] . Giglio F., Venstrom J.M., Gooley T.A., 2012

1. WJSC 6^(th) Anniversary Special Issues(1):Hematopoietic stem cell transplantation Allogeneic hematopoietic cell transplant for acute myeloid leukemia:Current state in 2013 and future directions [J] . Abraham S Kanate ,Marcelo C Pasquini ,Parameswaran N Hari . 世界干细胞杂志：英文版（电子版） . 2014,第2期

2. Graft vs host disease impacts overall survival post allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia/lymphoma [J] . Moussab Damlaj ,Mohammad Snnallah ,Ayman Alhejazi . 世界移植杂志 . 2018,第7期

3. 同种异体心脏移植中供体特异输注对肿瘤坏死因子α的影响 [C] . 司忠义 ,王中彬 ,谷春久 . 辽宁省第二届学术年会暨第五届青年学术年会 . 2005

4. KIR3DL1基因在无关供者HLA全相合异基因造血干细胞移植中的表达及临床意义 [A] . 张静 . 2015